Upon activation, aberrant NLRP3 inflammasome results in a robust release of mature IL-1β and IL-18, which plays key roles in a variety of diseases, including CNS disorders (Chen et al., 2013; Ma et al., 2014; Coll et al., 2015). The gene discussed is NLRP3; the disease is central nervous system disorder.